{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:31:59Z","timestamp":1782397919793,"version":"3.54.5"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Coxiella burnetii is an obligate intracellular bacterium and the causative agent of Q fever. C. burnetii is considered a potential bioterrorism agent because of its low infectious dose; resistance to heat, drying, and common disinfectants; and lack of prophylactic therapies. Q-Vax, a formalin-inactivated whole-bacteria vaccine, is currently the only prophylactic measure that is protective against C. burnetii infections but is not U.S. Food and Drug Administration approved. To overcome the safety concerns associated with the whole-bacteria vaccine, we sought to generate and evaluate recombinant protein subunit vaccines against C. burnetii. To accomplish this, we formulated C. burnetii Ags with a novel TLR triagonist adjuvant platform, which used combinatorial chemistry to link three different TLR agonists together to form one adjuvanting complex. We evaluated the immunomodulatory activity of a panel of TLR triagonist adjuvants and found that they elicited unique Ag-specific immune responses both in vitro and in vivo. We evaluated our top candidates in a live C. burnetii aerosol challenge model in C56BL\/6 mice and found that several of our novel vaccine formulations conferred varying levels of protection to the challenged animals compared with sham immunized mice, although none of our candidates were as protective as the commercial vaccine across all protection criteria that were analyzed. Our findings characterize a novel adjuvant platform and offer an alternative approach to generating protective and effective vaccines against C. burnetii.<\/jats:p>","DOI":"10.4049\/jimmunol.1900991","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T23:07:23Z","timestamp":1577142443000},"page":"611-621","source":"Crossref","is-referenced-by-count":31,"title":["Tuning Subunit Vaccines with Novel TLR Triagonist Adjuvants to Generate Protective Immune Responses against <i>Coxiella burnetii<\/i>"],"prefix":"10.1093","volume":"204","author":[{"given":"Adrienne P","family":"Gilkes","sequence":"first","affiliation":[{"name":"Vaccine Research and Design Center, Department of Physiology and Biophysics, University of California , Irvine, Irvine, CA 92697"},{"name":"Institute for Immunology, University of California , Irvine, Irvine, CA 92697"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler J","family":"Albin","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of California , Irvine, Irvine, CA 92697"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0809-5695","authenticated-orcid":false,"given":"Saikat","family":"Manna","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of California , Irvine, Irvine, CA 92697"},{"name":"The Institute for Molecular Engineering, The University of Chicago , Chicago, IL 60637"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2349-1271","authenticated-orcid":false,"given":"Medalyn","family":"Supnet","sequence":"additional","affiliation":[{"name":"Vaccine Research and Design Center, Department of Physiology and Biophysics, University of California , Irvine, Irvine, CA 92697"},{"name":"Institute for Immunology, University of California , Irvine, Irvine, CA 92697"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1134-6405","authenticated-orcid":false,"given":"Sara","family":"Ruiz","sequence":"additional","affiliation":[{"name":"U.S. Army Medical Research Institute of Infectious Diseases , Frederick, MD 21702"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Tom","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of California , Irvine, Irvine, CA 92697"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J","family":"Badten","sequence":"additional","affiliation":[{"name":"Vaccine Research and Design Center, Department of Physiology and Biophysics, University of California , Irvine, Irvine, CA 92697"},{"name":"Institute for Immunology, University of California , Irvine, Irvine, CA 92697"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Jain","sequence":"additional","affiliation":[{"name":"Vaccine Research and Design Center, Department of Physiology and Biophysics, University of California , Irvine, Irvine, CA 92697"},{"name":"Institute for Immunology, University of California , Irvine, Irvine, CA 92697"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Vaccine Research and Design Center, Department of Physiology and Biophysics, University of California , Irvine, Irvine, CA 92697"},{"name":"Institute for Immunology, University of California , Irvine, Irvine, CA 92697"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiin","family":"Felgner","sequence":"additional","affiliation":[{"name":"Vaccine Research and Design Center, Department of Physiology and Biophysics, University of California , Irvine, Irvine, CA 92697"},{"name":"Institute for Immunology, University of California , Irvine, Irvine, CA 92697"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D Huw","family":"Davies","sequence":"additional","affiliation":[{"name":"Vaccine Research and Design Center, Department of Physiology and Biophysics, University of California , Irvine, Irvine, CA 92697"},{"name":"Institute for Immunology, University of California , Irvine, Irvine, CA 92697"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel A","family":"Stetkevich","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of California , Irvine, Irvine, CA 92697"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Zlotnik","sequence":"additional","affiliation":[{"name":"Vaccine Research and Design Center, Department of Physiology and Biophysics, University of California , Irvine, Irvine, CA 92697"},{"name":"Institute for Immunology, University of California , Irvine, Irvine, CA 92697"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Pearlman","sequence":"additional","affiliation":[{"name":"Vaccine Research and Design Center, Department of Physiology and Biophysics, University of California , Irvine, Irvine, CA 92697"},{"name":"Institute for Immunology, University of California , Irvine, Irvine, CA 92697"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8581-7535","authenticated-orcid":false,"given":"Aysegul","family":"Nalca","sequence":"additional","affiliation":[{"name":"U.S. Army Medical Research Institute of Infectious Diseases , Frederick, MD 21702"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4117-8505","authenticated-orcid":false,"given":"Philip L","family":"Felgner","sequence":"additional","affiliation":[{"name":"Vaccine Research and Design Center, Department of Physiology and Biophysics, University of California , Irvine, Irvine, CA 92697"},{"name":"Institute for Immunology, University of California , Irvine, Irvine, CA 92697"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1273-0951","authenticated-orcid":false,"given":"Aaron P","family":"Esser-Kahn","sequence":"additional","affiliation":[{"name":"Vaccine Research and Design Center, Department of Physiology and Biophysics, University of California , Irvine, Irvine, CA 92697"},{"name":"The Institute for Molecular Engineering, The University of Chicago , Chicago, IL 60637"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M","family":"Burkhardt","sequence":"additional","affiliation":[{"name":"Vaccine Research and Design Center, Department of Physiology and Biophysics, University of California , Irvine, Irvine, CA 92697"},{"name":"Institute for Immunology, University of California , Irvine, Irvine, CA 92697"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,2,1]]},"reference":[{"key":"2025030417510556800_r1","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1016\/j.vaccine.2017.10.088","article-title":"Q-Vax Q fever vaccine failures, Victoria, Australia 1994-2013","volume":"35","author":"Bond","year":"2017","journal-title":"Vaccine"},{"key":"2025030417510556800_r2","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1080\/21645515.2017.1371377","article-title":"Q-vaxcelerate: a distributed development approach for a new Coxiella burnetii vaccine","volume":"13","author":"Reeves","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"2025030417510556800_r3","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fmicb.2014.00726","article-title":"Vaccination against Q fever for biodefense and public health indications","volume":"5","author":"Ruiz","year":"2014","journal-title":"Front. Microbiol."},{"key":"2025030417510556800_r4","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/imj.13488","article-title":"The need for better preventative strategies for inflammatory bowel disease patients at risk of herpes zoster virus","volume":"47","author":"Bye","year":"2017","journal-title":"Intern. Med. J."},{"key":"2025030417510556800_r5","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.vaccine.2018.01.028","article-title":"Immunogenicity and protective efficacy of recombinant fiber-2 protein in protecting SPF chickens against fowl adenovirus 4","volume":"36","author":"Chen","year":"2018","journal-title":"Vaccine"},{"key":"2025030417510556800_r6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.11.1.1","article-title":"Use of licensed vaccines for active immunization of the immunocompromised host","volume":"11","author":"Pirofski","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"2025030417510556800_r7","first-page":"168","article-title":"Successful immune response to a recombinant hepatitis B vaccine in children after liver transplantation","volume":"32","author":"Duca","year":"2001","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"2025030417510556800_r8","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3389\/fimmu.2017.01760","article-title":"AS03- and MF59-adjuvanted influenza vaccines in children","volume":"8","author":"Wilkins","year":"2017","journal-title":"Front. Immunol."},{"key":"2025030417510556800_r9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/mmy\/myu045","article-title":"Adjuvants and delivery systems for antifungal vaccines: current state and future developments","volume":"53","author":"Portuondo","year":"2015","journal-title":"Med. Mycol."},{"key":"2025030417510556800_r10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4110\/in.2015.15.2.51","article-title":"Recent advances of vaccine adjuvants for infectious diseases","volume":"15","author":"Lee","year":"2015","journal-title":"Immune Netw."},{"key":"2025030417510556800_r11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1586\/14760584.6.5.699","article-title":"MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection","volume":"6","author":"O\u2019Hagan","year":"2007","journal-title":"Expert Rev. Vaccines"},{"key":"2025030417510556800_r12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri2629","article-title":"Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology","volume":"9","author":"Pulendran","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"2025030417510556800_r13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"2025030417510556800_r14","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.22","article-title":"Toll-like receptors: the swiss army knife of immunity and vaccine development","volume":"5","author":"Dowling","year":"2016","journal-title":"Clin. Transl. Immunology"},{"key":"2025030417510556800_r15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tibtech.2018.10.004","article-title":"Applications of immunomodulatory immune synergies to adjuvant discovery and vaccine development","volume":"37","author":"Tom","year":"2019","journal-title":"Trends Biotechnol."},{"key":"2025030417510556800_r16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009980","article-title":"Rational design of small molecules as vaccine adjuvants","volume":"6","author":"Wu","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"2025030417510556800_r17","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/nbt.3371","article-title":"In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity","volume":"33","author":"Lynn","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"2025030417510556800_r18","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1021\/acscentsci.8b00823","article-title":"Linked toll-like receptor triagonists stimulate distinct, combination-dependent innate immune responses","volume":"5","author":"Albin","year":"2019","journal-title":"ACS Cent. Sci."},{"key":"2025030417510556800_r19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrmicro3049","article-title":"Molecular pathogenesis of the obligate intracellular bacterium Coxiella burnetii","volume":"11","author":"van Schaik","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"2025030417510556800_r20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/CMR.00045-16","article-title":"From Q fever to Coxiella burnetii infection: a paradigm change","volume":"30","author":"Eldin","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"2025030417510556800_r21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/CVI.00613-12","article-title":"Long-Term immune responses to Coxiella burnetii after vaccination","volume":"20","author":"Kersh","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"2025030417510556800_r22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1017\/S0950268800059458","article-title":"Vaccine prophylaxis of abattoir-associated Q fever: eight years\u2019 experience in Australian abattoirs","volume":"104","author":"Marmion","year":"1990","journal-title":"Epidemiol. Infect."},{"key":"2025030417510556800_r23","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1128\/iai.61.4.1251-1258.1993","article-title":"Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever","volume":"61","author":"Fries","year":"1993","journal-title":"Infect. Immun."},{"key":"2025030417510556800_r24","first-page":"389","article-title":"Immunogenicity and reactogenicity of a Q fever chemovaccine in persons professionally exposed to Q fever in Czechoslovakia","volume":"60","author":"Kaz\u00e1r","year":"1982","journal-title":"Bull. World Health Organ."},{"key":"2025030417510556800_r25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S1473-3099(03)00804-1","article-title":"Q fever: a biological weapon in your backyard","volume":"3","author":"Madariaga","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"2025030417510556800_r26","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1021\/jm301694x","article-title":"Identification of substituted pyrimido[5,4-b]indoles as selective toll-like receptor 4 ligands","volume":"56","author":"Chan","year":"2013","journal-title":"J. Med. Chem."},{"key":"2025030417510556800_r27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.vascn.2003.07.001","article-title":"The automated bioaerosol exposure system: preclinical platform development and a respiratory dosimetry application with nonhuman primates","volume":"49","author":"Hartings","year":"2004","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"2025030417510556800_r28","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.3390\/v4123468","article-title":"Development of a murine model for aerosolized ebolavirus infection using a panel of recombinant inbred mice","volume":"4","author":"Zumbrun","year":"2012","journal-title":"Viruses"},{"key":"2025030417510556800_r29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1152\/ajplegacy.1947.150.1.70","article-title":"Measurement of the respiratory volumes of laboratory animals","volume":"150","author":"Guyton","year":"1947","journal-title":"Am. J. Physiol."},{"key":"2025030417510556800_r30","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1002\/pmic.201000064","article-title":"Genome-wide profiling of humoral immune response to Coxiella burnetii infection by protein microarray","volume":"10","author":"Vigil","year":"2010","journal-title":"Proteomics"},{"key":"2025030417510556800_r31","first-page":"M110.006304","article-title":"Profiling the humoral immune response of acute and chronic Q fever by protein microarray","volume-title":"Mol. Cell Proteomics","author":"Vigil","year":"2011"},{"key":"2025030417510556800_r32","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/CVI.00300-08","article-title":"Candidate antigens for Q fever serodiagnosis revealed by immunoscreening of a Coxiella burnetii protein microarray","volume":"15","author":"Beare","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"2025030417510556800_r33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/prca.201200096","article-title":"The contribution of proteomics towards deciphering the enigma of Coxiella burnetii","volume":"7","author":"Vranakis","year":"2013","journal-title":"Proteomics Clin. Appl."},{"key":"2025030417510556800_r34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0167-5699(87)90171-X","article-title":"Two types of mouse helper T-cell clone implications for immune regulation","volume":"8","author":"Mosmann","year":"1987","journal-title":"Immunol. Today"},{"key":"2025030417510556800_r35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12026-008-8059-4","article-title":"Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii","volume":"43","author":"Shannon","year":"2009","journal-title":"Immunol. Res."},{"key":"2025030417510556800_r36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/978-94-007-4315-1_14","article-title":"Role of innate and adaptive immunity in the control of Q fever","volume":"984","author":"Capo","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"2025030417510556800_r37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097503","article-title":"Persistence of Coxiella burnetii, the agent of Q fever, in murine adipose tissue","volume":"9","author":"Bechah","year":"2014","journal-title":"PLoS One"},{"key":"2025030417510556800_r38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0021-9975(08)80219-8","article-title":"Spread and distribution of Coxiella burnetii in C57BL\/6J (H-2b) and Balb\/cJ (H-2d) mice after intraperitoneal infection","volume":"108","author":"Baumg\u00e4rtner","year":"1993","journal-title":"J. Comp. Pathol."},{"key":"2025030417510556800_r39","first-page":"469","article-title":"Animal models of Q fever (Coxiella burnetii)","volume":"63","author":"Bewley","year":"2013","journal-title":"Comp. Med."},{"key":"2025030417510556800_r40","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0264-410X(97)00107-2","article-title":"Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol","volume":"15","author":"Waag","year":"1997","journal-title":"Vaccine"},{"key":"2025030417510556800_r41","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.4049\/jimmunol.179.12.8372","article-title":"Mechanisms of vaccine-induced protective immunity against Coxiella burnetii infection in BALB\/c mice","volume":"179","author":"Zhang","year":"2007","journal-title":"J. Immunol."},{"key":"2025030417510556800_r42","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1574-695X.2007.00272.x","article-title":"Coxiella burnetii infection in C57BL\/6 mice aged 1 or 14 months","volume":"50","author":"Leone","year":"2007","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"2025030417510556800_r43","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.4049\/jimmunol.158.3.1085","article-title":"Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells","volume":"158","author":"Nakamura","year":"1997","journal-title":"J. Immunol."},{"key":"2025030417510556800_r44","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.4049\/jimmunol.157.4.1350","article-title":"A direct role for IFN-gamma in regulation of Th1 cell development","volume":"157","author":"Bradley","year":"1996","journal-title":"J. Immunol."},{"key":"2025030417510556800_r45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fimmu.2016.00427","article-title":"Modulation of primary immune response by different vaccine adjuvants","volume":"7","author":"Ciabattini","year":"2016","journal-title":"Front. Immunol."},{"key":"2025030417510556800_r46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of action of adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Front. Immunol."},{"key":"2025030417510556800_r47","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1006\/expr.1996.0121","article-title":"Taenia saginata: vaccination against cysticercosis in cattle with recombinant oncosphere antigens","volume":"84","author":"Lightowlers","year":"1996","journal-title":"Exp. Parasitol."},{"key":"2025030417510556800_r48","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-3024.1996.d01-90.x","article-title":"Comparative vaccination of cattle against Boophilus microplus with recombinant antigen Bm86 alone or in combination with recombinant Bm91","volume":"18","author":"Willadsen","year":"1996","journal-title":"Parasite Immunol."},{"key":"2025030417510556800_r49","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1128\/iai.65.3.1109-1113.1997","article-title":"A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines","volume":"65","author":"Duffy","year":"1997","journal-title":"Infect. Immun."},{"key":"2025030417510556800_r50","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.vetpar.2006.06.010","article-title":"Vaccination of calves with an attenuated cell line of Theileria annulata and the sporozoite antigen SPAG-1 produces a synergistic effect","volume":"142","author":"Darghouth","year":"2006","journal-title":"Vet. Parasitol."},{"key":"2025030417510556800_r51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4149\/av_2010_03_173","article-title":"Characterization of antigens for Q fever serodiagnostics","volume":"54","author":"Sekeyov\u00e1","year":"2010","journal-title":"Acta Virol."},{"key":"2025030417510556800_r52","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1016\/j.vaccine.2012.09.017","article-title":"Mice immunized with bone marrow-derived dendritic cells stimulated with recombinant Coxiella burnetii Com1 and Mip demonstrate enhanced bacterial clearance in association with a Th1 immune response","volume":"30","author":"Xiong","year":"2012","journal-title":"Vaccine"},{"key":"2025030417510556800_r53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2180-12-35","article-title":"Potential serodiagnostic markers for Q fever identified in Coxiella burnetii by immunoproteomic and protein microarray approaches","volume":"12","author":"Xiong","year":"2012","journal-title":"BMC Microbiol."},{"key":"2025030417510556800_r54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205882","article-title":"Standardized guinea pig model for Q fever vaccine reactogenicity","volume":"13","author":"Baeten","year":"2018","journal-title":"PLoS One"},{"key":"2025030417510556800_r55","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1586\/14760584.3.5.577","article-title":"Vaccines against Coxiella infection","volume":"3","author":"Zhang","year":"2004","journal-title":"Expert Rev. Vaccines"},{"key":"2025030417510556800_r56","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1749-6632.1992.tb19633.x","article-title":"Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals","volume":"653","author":"Williams","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2025030417510556800_r57","first-page":"327","article-title":"Protective immunity induced by 67 K outer membrane protein of phase I Coxiella burnetii in mice and guinea pigs","volume":"38","author":"Zhang","year":"1994","journal-title":"Acta Virol."},{"key":"2025030417510556800_r58","doi-asserted-by":"crossref","first-page":"28538","DOI":"10.1039\/C6CP04474C","article-title":"Metallic cyanoacetylides of copper, silver and gold: generation and structural characterization","volume":"18","author":"Cabezas","year":"2016","journal-title":"Phys. Chem. Chem. Phys."},{"key":"2025030417510556800_r59","doi-asserted-by":"crossref","first-page":"10612","DOI":"10.1128\/JVI.01526-15","article-title":"Enhanced influenza virus-like particle vaccination with a structurally optimized RIG-I agonist as adjuvant","volume":"89","author":"Beljanski","year":"2015","journal-title":"J. Virol."},{"key":"2025030417510556800_r60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079194","article-title":"Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodies","volume":"8","author":"Goff","year":"2013","journal-title":"PLoS One"},{"key":"2025030417510556800_r61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191896","article-title":"Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools","volume":"13","author":"Sasaki","year":"2018","journal-title":"PLoS One"},{"key":"2025030417510556800_r62","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1016\/j.vaccine.2013.05.007","article-title":"The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect","volume":"31","author":"Calabro","year":"2013","journal-title":"Vaccine"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/204\/3\/611\/61361241\/ji1900991.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/204\/3\/611\/61361241\/ji1900991.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T18:03:20Z","timestamp":1741111400000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/204\/3\/611\/7944000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1900991","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,2]]},"published":{"date-parts":[[2020,2,1]]}}}